Harmony Biosciences (HRMY) SEC Filings & 10K Form

$29.23
+0.38 (+1.32%)
(As of 04/24/2024 ET)

Recent Harmony Biosciences SEC Filings

DateFilerForm TypeView
04/11/2024
8:44 AM
Harmony Biosciences (Filer)
Form ARS
04/11/2024
7:30 AM
Harmony Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/11/2024
7:17 AM
Harmony Biosciences (Filer)
Form DEF 14A
04/11/2024
7:18 AM
Harmony Biosciences (Filer)
Form DEFA14A
03/18/2024
6:24 PM
Dierks Jeffrey (Reporting)
Harmony Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/15/2024
3:24 PM
Dierks Jeffrey (Reporting)
Harmony Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/11/2024
4:17 PM
Dierks Jeffrey (Reporting)
Harmony Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
3:21 PM
Dierks Jeffrey (Reporting)
Harmony Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/28/2024
4:16 PM
Harmony Biosciences (Filer)
Form 10-K/A
02/22/2024
7:00 AM
Harmony Biosciences (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/22/2024
6:45 AM
Harmony Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/13/2024
6:06 PM
Harmony Biosciences (Subject)
Valor IV Pharma Holdings, LLC (Filed by)
Form SC 13G/A
01/24/2024
1:27 PM
BlackRock Inc. (Filed by)
Harmony Biosciences (Subject)
Form SC 13G/A
01/08/2024
7:30 AM
Harmony Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/08/2023
7:59 AM
Anastasiou Peter (Reporting)
Harmony Biosciences (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
11/08/2023
8:03 AM
Anastasiou Peter (Reporting)
Harmony Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/08/2023
7:30 AM
Harmony Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/31/2023
7:00 AM
Harmony Biosciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/31/2023
6:45 AM
Harmony Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/13/2023
7:15 AM
Harmony Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/11/2023
7:31 AM
Harmony Biosciences (Filed by)
Zynerba Pharmaceuticals, Inc. (Subject)
Form SC TO-T/A
10/11/2023
7:15 AM
Harmony Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/06/2023
1:34 PM
BlackRock Inc. (Filed by)
Harmony Biosciences (Subject)
Form SC 13G/A
10/05/2023
3:15 PM
Harmony Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/05/2023
3:15 PM
Harmony Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/04/2023
7:00 AM
Harmony Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/27/2023
7:12 AM
Harmony Biosciences (Filed by)
Zynerba Pharmaceuticals, Inc. (Subject)
Form SC TO-T/A
09/25/2023
7:00 AM
Harmony Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/14/2023
3:59 PM
Harmony Biosciences (Filed by)
Zynerba Pharmaceuticals, Inc. (Subject)
Form SC TO-T/A
09/14/2023
3:42 PM
Harmony Biosciences (Filer)
Form 8-K/A
08/28/2023
7:23 AM
Harmony Biosciences (Filed by)
Zynerba Pharmaceuticals, Inc. (Subject)
Form SC TO-T
08/24/2023
4:23 PM
Harmony Biosciences (Filed by)
Zynerba Pharmaceuticals, Inc. (Subject)
Form SC 13D
08/14/2023
4:26 PM
Harmony Biosciences (Filed by)
Zynerba Pharmaceuticals, Inc. (Subject)
Form SC TO-C
08/14/2023
4:27 PM
Harmony Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2023
4:29 PM
Harmony Biosciences (Filed by)
Zynerba Pharmaceuticals, Inc. (Subject)
Form SC TO-C
08/01/2023
7:01 AM
Harmony Biosciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/01/2023
6:45 AM
Harmony Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/27/2023
7:30 AM
Harmony Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/31/2023
3:37 PM
Dayno Jeffrey M. (Reporting)
Harmony Biosciences (Issuer)
Form 4/A
05/26/2023
4:25 PM
Harmony Biosciences (Issuer)
Nielsen Jack (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/26/2023
3:20 PM
Gracias Antonio J. (Reporting)
Harmony Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL) (Ad)

AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.

Click here now for the full details of this stock that’s set to rocket in the AI revolution…
05/26/2023
3:26 PM
Harmony Biosciences (Issuer)
Sabater Juan A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/02/2023
7:00 AM
Harmony Biosciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/02/2023
7:20 AM
Harmony Biosciences (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
05/02/2023
6:45 AM
Harmony Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/24/2023
7:30 AM
Harmony Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:HRMY) was last updated on 4/24/2024 by MarketBeat.com Staff

From Our Partners